Office Of Clinical Trials. Christine Nelson, RN, BSN, MBA, CCRC

Similar documents
Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network for Research Professionals

10/9/2012. Alicia Joy, IRB. Wednesday October 10, Please be sure to sign in and take copies of each handout.

DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR CLINICAL RESEARCH

ClinicalTrials.gov REGISTRATION REQUIREMENTS

Human Subjects Research Policy Update. Naomi Coll Director of Research Policy and Compliance

Terry Sousa UMass Medical School PRS Administrator for Clinicaltrials.gov

ROLE OF THE RESEARCH COORDINATOR Study Startup Best Practices May 2016

Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd.

FDA Sponsor and Investigator Responsibility Checklist

Sponsor-Investigator Responsibilities In Clinical Trials

Human Research Protection Program Policy

Quality Assurance QA STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits

Research 101. Health Care Compliance Association Regional Conference Columbus, Ohio May 8, 2015

GCP INSPECTION FINDINGS Singapore Research Ethics Conference 2018

Mini Rounds Wednesday, May 21, 2014

POST-IRB APPROVAL FDA DRUG (IND) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR312)

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework

Effectively Preparing for and Responding to an FDA Audit: The Research Team s Perspective

April 13, Background

IRB Considerations for Investigator-Initiated Research

1 The Clinical Research Coordinator (CRC)... 1

UC DAVIS OFFICE OF RESEARCH AAHRPP Preparation UC Davis Human Research Part III Investigator Manual. Cindy Gates IRB Administration

VCU Faculty Held IND and IDE Procedure Handbook

Conducted Under an IND to Support a

The Johns Hopkins Institute for Clinical and Translational Research

4.2. Investigator Regulatory Binder: Files, usually a binder, maintained by the investigator at the investigative site.

OCTC 2012 CRO Selection

Standard Operating Procedures (SOPs)

Regulatory Binder Guidance

U.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE. Jeff Shuren Director Center for Devices and Radiological Health

DEVELOPING CLINICAL TRIALS INFRASTRUCTURE

Clinical Trials Registration: Your Obligations

Doing Human Subjects Research? Changing NIH Policies May Impact You

Toward Greater Transparency and Rigor

Industry-Sponsored Clinical Trials Improvement Efforts

HCCA 13 TH ANNUAL COMPLIANCE INSTITUTE LAS VEGAS, NV APRIL 29, 2009

Clinical Research with Drugs/Biologics and Devices & Good Clinical Practices

ClinicalTrials.gov Registration Guide

Recommendations for Strengthening the Investigator Site Community

Human Research Protection Program Policy

\\NAS1\George\Docs\SoCRA\CCRP communications\study guide management

Becoming Aware of the Requirements Surrounding Clinical Trial Disclosure (ClinicalTrials.gov)

Implementing Good Clinical Practice at an Academic Research Institution

Human Research Protection Program Good Clinical Practice Guidance for Investigators Regulatory File Essential Documents

EU Clinical Trial Regulation A view from the Industry

TITLE: DF/HCC Investigator-Sponsored Multi-Center Research POLICY #: MULTI-100 Page: 1 of 4 Effective Date: 1/31/19

Clinical Trials Office VPR CTO

Effective Date: October 8, 2015 Policy Number: MHC_RP0301. Corporate Director, HRPP Institutional Official, HRPP

ClinicalTrials.gov Registration Guide

ClinicalTrials.gov. Why Does it Affect Me? Should I Be Concerned?

Obtaining Pre-Study Approvals for Clinical Trials K-30 Module 5 Navigating the Pre-Award Process

Sponsor/Investigator Responsibilities

and Study Initiation

and Study Initiation

HUMAN RESEARCH PROTECTION PROGRAM PLAN

3.0 HSC Relation to Other KUMC Committees

A SHORT GUIDE TO THE PROCEDURE FOR A CLINICAL TRIAL APPLICATION IN THE KINGDOM OF BAHRAIN

Standard Operating Procedures Guidelines for Good Clinical Practice

Establishment of Clinical Trial Infrastructure

The In Vitro Diagnostic CRO

Guidelines for Setting Up a Regulatory Binder

Regulatory Documentation and Submissions for C2012 Clinical Trials DCP SOP #1

Department At-A-Glance

A Research Compliance Program

Clinical Trials Series Part II

ClinicalTrials.gov Updates. Gabrielle Gaspard Assistant Director Human Research Compliance

1.0 INTRODUCTION AND OVERVIEW

TITLE: DF/HCC Investigator-Sponsored Multi-Center TrialsResearch POLICY #: MULTI-100 Page: 11 of 54 Effective Date: 8/31/17 1.

SOCIETY OF RESEARCH ADMINISTRATORS ORLANDO FLORIDA OCTOBER 2018

Investigational New Drug Development Steps for CRCs

SELF-ASSESSMENT CHECKLIST

Human Subjects Protection Program Plan

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE

Structuring Compliance: The Duke Model

Structuring Compliance: The Duke Model

Clinical Trial Disclosure: Current US Situation

COI V September Draft. USC Conflict of Interest Disclosure System (COIDS) System Requirements V1.0 (Draft)

1. POLICY STATEMENT: 2. BACKGROUND:

Clinical Research at MSU

Good Clinical Practice Compliance

MCRA Clinical More Than Your Average CRO. Clinical Project Management. Site Management and Study Monitoring. Data Management. Auxiliary Services

Compliance and Quality Monitoring: What, Why, When, and How

The Research Services Organization (RSO) of the Academic Health Center

CDER Perspective: Good Clinical Practice

Melanie Hawkins, BSN, RN, CCRC Director, Clinical Research Billing Compliance Kristin Pattee Couture, CCRP Clinical Research Coverage Analyst

ClinicalTrials.gov Registration and Results Reporting: Updates and Recent Activity

CAPA Management: Best Practices and FDA QSR Mandate WHITE PAPER. ComplianceQuest In-Depth Analysis and Review

Why Industry Collaborations Matter TransCelerate BioPharma, Inc.

Standard Operating Procedure

Investigational New Drug (IND) & Investigational Device Exemptions (IDE) Applications Preparation and Submission, and Conducting FDA Meetings

NIH Policy on Dissemination of NIH- Funded Clinical Trial Information

August 3, 2017 Closeout Management. UNC Symposium for Research Administrators

The Brave New World of Medical Devices

Regulatory Binder: Set-up and Maintenance

ICH GCP E6(R2): Changes? Yes Challenges? Not as Difficult as You May Fear Lorrie D. Divers, President QRCP Solutions, Inc.

Good Clinical Practice (GCP) & Clinical Trial Registries

Strasser, Jane (strassje)

What you missed at the: 2 nd Clinical Trials Inspection Readiness Summit August 2013 Philadelphia, PA

Human Research Protection Program. Plan

Guidance for IRBs, Clinical Investigators and Sponsors

Transcription:

Office Of Clinical Trials Christine Nelson, RN, BSN, MBA, CCRC

OCT Mission Statement The mission of the Office of Clinical Trials (OCT) is to serve the Carolina research community by improving the quality of support by facilitating and streamlining the startup, conduct and administration of clinical trials. In support of that mission, the OCT strives to: 1) Standardize the processes for clinical trials to ensure consistency, efficiency, and compliance with Federal, State and University requirements; 2) Provide educational opportunities to research faculty and staff; 3) Facilitate regulatory knowledge and support to investigators and clinical research professionals to enhance compliance with federal and institutional requirements; 4) Identify and/or support development of new clinical research opportunities in collaboration with our clinical research teams; 5) Encourage interdisciplinary collaboration for clinical research and incorporate available resources throughout the University and UNC Health Care.

Clinical Trial Quality Assurance Program Routine Reviews Post Approval Reviews Directed Reviews OHRE Department head Vice Chancellor for Research Preparation for External Reviews FDA Sponsor Audits Assist with external audits/inspections

Clinical Trial Quality Assurance Program Conducted 57 post approval reviews Assisted with 5 FDA inspection Conducted 3 root cause analyses (RCA) with departments to assist with the development of Corrective and preventative Action Plans (CAPA) Assisted with draft communications with the FDA Collaborated with two prominent Clinical Research Organizations to improve the quality of the clinical trials conducted at UNC

Clinical Trial Quality Assurance Program Forms and checklists available on our website Track GCP training Will begin tracking and trending sponsor monitor follow up reports Draft policies

PS Project ID Set up Conduct compliance review prior to PS project ID set up by OSR GCP training completed and current IRB approval IPF submission with internal budget COI training, disclosure and review complete Congruency of BCA, CTA and ICF

Clinical Trial Billing Compliance Review and assistance with the Billing Coverage Analysis Ensures consistency of BCA, CTA and ICF prior to account set up Research 100 classes, monthly Now available CITI training on Clinical Trial Billing Compliance Clinical Trial Billing reviews to start soon

ClinicalTrials.gov Support with registration and results reporting for ClinicalTrials.gov Alerts investigators when trials appear on the problem report for late results reporting

ClinicalTrials.gov Final rule announced September 16, 2016 Effective date January 18, 2017, 90 days to come into compliance April 18, 2017 Clarification and expansion of the definition of an applicable clinical trial Clarified responsible party Clarified and increased the results reporting Need full protocol, including a statistical Analysis plan NIH can withhold funding if there is failure to report results

CRMS Support Provide customer and technical support for CRMS Proactively troubleshoot issues Perform Quality Assurance/Quality Control of the CRMS System and development measures. Training Research 100 One on one

Scientific Review Committee Need for the separation of the scientific review from the IRB review Administrative support Require full protocol with statistical analysis plan In line with new NIH and CT.gov final rule Goal to improve turn around times for IRB review Improve the quality of protocols SRC will no longer review industry sponsored protocols

Support New research Opportunities Clinical research staffing is key to the success of the investigator and the study Investigators may have a desire to lead clinical trials but lack the required study support resources due to difficulty in recruiting, retaining and efficiently onboarding staff. UNC has launched a pilot program with a commercial partner to offer site-management services to investigators and departments with limited infrastructure.

Future Prepaid card for study subject payments IND/IDE registration with OCT Policy on delegation of tasks Enterprise wide clinical trials management system

Last thought

Questions